NCT02860858View on ClinicalTrials.gov

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

August 30, 2018

Study Completion Date

December 31, 2018

Conditions
Symtomatic Macular Polypoidal Choroidal Vasculopathy
Interventions
BIOLOGICAL

Intravitreous aflibercept injection

Trial Locations (1)

10400

Rajavithi Hospital, Bangkok

All Listed Sponsors
lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV

NCT02860858 - Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV) | Biotech Hunter | Biotech Hunter